Ann DeWitt

ImmuneXcite, Inc. operates as a biopharmaceutical company which develops monoclonal antibodies for cancer. The firm provides nivel immuno-incology technology platform, which leverages both the innate and adaptive immune responses to selectively treat a wide range of tumor types. The company was Ifat Rubin-Bejerano, Gerald R. Fink and Yaniv Bejerano and is headquartered in Waltham, MA.

Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA.

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts.

Permeon Biologics, Inc. develops intracellular biotherapeutics platform to enhance drug delivery. Its intraphilin technology platform leverages research on remodeling the surfaces of proteins to permit cell penetration without losing their structure or activity; and enables functional proteins to replace or restore defective pathways inside cells that cause disease. The company was founded by Douglas G. Cole, David R. Liu, John W. Ripple, and Noubar B. Afeyan in 2008 and is headquartered in Cambridge, MA.

The Engine Accelerator, Inc. (The Engine) is a venture capital firm founded in 2016. The firm is headquartered in Cambridge, Massachusetts.

Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA.

Cambridge Crops, Inc. provides edible and natural biomaterial coating services. It uses salt and water to extract the protein from silk to create an edible protective layer that keeps food fresh for longer. The company was founded by Fiorenzo Omenetto, Livio Valenti, Jacques-Henry Grislain and Benedetto Marelli and is headquartered in Boston, MA.

Lucy Therapeutics, Inc. operates as a biotech firm. It offers a novel approach to drug discovery by drugging targets associated with early disease pathogenesis. The company was founded by Amy Ripka and is headquartered in Cambridge, MA.